Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention.
Boden
William E
WE
Maron
David J
DJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007902:Length of Stay; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality* / Q000503:physiopathology / Q000517:prevention & control*; D010351:Patient Discharge; D011379:Prognosis; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D002317:Cardiovascular Agents; D000960:Hypolipidemic Agents